SEC Form 4 · accession 0001093557-26-000127
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Coleman
Officer — EVP, Chief Commercial Officer
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 4:17 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 3, 2026 | S | 4,912 | $73.00 | D | 100,361 | D | |
| Common StockF1,F2 | Jun 4, 2026 | S | 4,911 | $74.13 | D | 95,450 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 4, 2026, Mr. Coleman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Coleman. The shares set forth above were sold pursuant to the 10b5- 1 Plan.
- F2Included in this number are 95,450 unvested restricted stock units, 43,897 of which were granted on March 8, 2026 and shall vest through March 8, 2029, and 51,553 of which were granted on May 22, 2025 and shall vest through May 22, 2029.